Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pelvic vs Extended-field Irradiation in Cervical Cancer
NCT03955367Phase 3Unknown
- Sponsor
- Peking Union Medical College Hospital
- Start
- Jun 2019
- Primary completion
- Jun 2022
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in Cervical Cancer (CC) (2 arms), sponsored by Peking Union Medical College Hospital. Primary endpoint: Progression-free survival at 3 years. Status: unknown.
02
Conditions
Cervical Cancer (CC)
Beyond the preview
Go deeper on NCT03955367.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03955367.